IAM

Iambic Therapeutics Inc

20.01

Oct 16 • 8:41 AM ET +1.10 (5.82%)

Healthcare Biotechnology USA Small NASD

Oct 15, 8:31 PMIambic Therapeutics pops 18% in Nasdaq debut after $150 million IPO

Index	-
Market Cap	948.49M
Enterprise Value	-
Income	-
Sales	-
Book/sh	-
Cash/sh	-
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Oct 15, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	2.83%
SMA50	2.83%
SMA200	2.83%
Trades

Shs Outstand	47.40M
Shs Float	-
Short Float	-
Short Ratio	-
Short Interest	-
52W High	19.70 1.57%
52W Low	16.15 23.90%
Volatility	- -
ATR (14)	2.62
RSI (14)	-
Beta	-
Rel Volume	0.35
Avg Volume	2.02M
Volume	35,568

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	23.90%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	18.91
Price	20.01
Change %	5.82%

Oct-15-26 01:38PM

Cathie Wood-Backed Biotech IPO Pops in Debut

(Barrons.com)

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded 2019 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IAM

Iambic Therapeutics Inc

Upgrade your Finviz experience